Beranda › Glomerulosklerosis Segmental Fokal › Georgia
Uji klinis Glomerulosklerosis Segmental Fokal di Georgia
6 studi untuk Glomerulosklerosis Segmental Fokal mencari peserta di lokasi di Georgia.
Kota di Georgia
Teks studi resmi (Bahasa Inggris)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #29, Augusta
- Investigator Site # 1, Lawrenceville
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Emory Children's Center, Atlanta
- Coastal Medical Research, LLC, Brunswick
- Southeast Kidney Associates - East Point, East Point
- dan 1 lainnya
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Emory Children's Center- Site Number : 8400020, Atlanta
Menerima pesertaFase 2
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06500702Nephrotic Syndrome Study Network
- Emory University and Children's Healthcare of Atlanta, Atlanta
Menerima pesertaStudi observasional
Hingga usia 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT01209000NEPTUNE Match Study
- Emory University Hospital - Children's Hospital of Atlanta, Atlanta
Menerima peserta
Usia 1 hingga 80 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT04571658A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Emory University School of Medicine, Atlanta
Menerima pesertaFase 3
Usia 12 hingga 80 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05183646Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.